Cargando…
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
Since the beginning of the SARS-CoV-2(severe acute respiratory syndrome-coronavirus-2) pandemic, a race to develop a vaccine has been initiated, considering the massive and rather significant economic and healthcare hits that this virus has caused. The pathophysiology occurring following COVID-19(co...
Autores principales: | Elgohary, Sawsan, Elkhodiry, Aya A., Amin, Nada S., Stein, Ulrike, El Tayebi, Hend M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912962/ https://www.ncbi.nlm.nih.gov/pubmed/33540625 http://dx.doi.org/10.3390/cells10020302 |
Ejemplares similares
-
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
por: Elgohary, Sawsan, et al.
Publicado: (2023) -
Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis
por: Elkhodiry, Aya A., et al.
Publicado: (2021) -
MicroRNA‑155 modulation of CD8(+) T‑cell activity personalizes response to disease‑modifying therapies of patients with relapsing‑remitting multiple sclerosis
por: Elkhodiry, Aya A., et al.
Publicado: (2023) -
The Record Breakers
por: Peplow, Mark
Publicado: (2016) -
Breakers Ahead
Publicado: (1892)